Izicelo eziningi ze-paclitaxel emkhakheni wokwelapha isimila

I-Paclitaxel iyisidakamizwa esinamandla sokulwa nomdlavuza esibe yingxenye ebalulekile yokwelashwa komdlavuza ngenxa yendlela eyingqayizivele kanye nezinzuzo eziningi zokwelapha.Umuthi ekuqaleni wawuhlukanisiwe ne-Pacific yew tree (Taxus brevifolia) ngo-1971, futhi ngemva kweminyaka yocwaningo nokuthuthuka, ususetshenziswe kabanzi emikhakheni eminingi yomdlavuza.Leli phepha lizokwethula izindawo zokusebenza eziyinhloko zepaclitaxel APIkanye neqhaza layo elibalulekile kulezi zindawo.

1. Ukwelashwa komdlavuza wesibeletho:

I-Paclitaxelngokuvamile isetshenziselwa ukwelapha umdlavuza wesibeletho.Ingasetshenziswa njengokwelashwa komugqa wokuqala noma, kanye neminye imithi, njengokwelashwa okungeziwe komdlavuza wesibeletho othuthukile.I-Paclitaxel ivimbela ngempumelelo ukukhula nokusabalala kwamangqamuzana omdlavuza ngokuphazamisa i-mitosis yamaseli wesimila.

2. Ukwelashwa Komdlavuza Webele:

Ezigulini ezinomdlavuza webele, i-paclitaxel ivamise ukusetshenziswa ngokuhlanganiswa nezinye izidakamizwa ezilwa nomdlavuza, ikakhulukazi umdlavuza webele osuthuthukile noma ophindelelayo.Kuyasiza ukunciphisa usayizi wesimila futhi kuthuthukise ukusebenza kahle kokwelashwa.

3. Ukwelashwa komdlavuza wamaphaphu:

Umdlavuza wamaphaphu ongewona omncane (NSCLC) uwuhlobo oluvamile lomdlavuza wamaphaphu, futhi i-paclitaxel isetshenziswa kabanzi njengokwelashwa komugqa wokuqala noma i-adjuvant ye-NSCLC.Kuyasiza ukunciphisa izinga lokukhula kwezimila futhi kuthuthukise amazinga okusinda.

4. Ukwelashwa komdlavuza womlomo wesibeletho:

I-Paclitaxel isetshenziswa ngokuhlanganyela ne-Cisplatin ekwelapheni umdlavuza womlomo wesibeletho, ngokuvamile njengengxenye yokwelapha ngemisebe ye-adjuvant.Lokhu kwelashwa okuhlangene kuthuthukise kakhulu izinga lokusinda kweziguli ezinomdlavuza womlomo wesibeletho.

5. Ukwelashwa komdlavuza wesisu:

I-Paclitaxel kwesinye isikhathi isetshenziswa ekwelapheni umdlavuza wesisu noma wommizo, imvamisa ihlanganiswa neminye imishanguzo elwa nomdlavuza ukunciphisa ukukhula nokusabalala kwesimila.

6. Ukwelashwa Komdlavuza Wendlala Yesinye:

I-Paclitaxel futhi ingasetshenziswa ekwelapheni umdlavuza wendlala yesinye, ikakhulukazi lapho umdlavuza ususabalele kwezinye izitho.Ingakwazi ukulawula ukukhula kwezimila futhi inciphise izimpawu.

7. Ukwelashwa Komdlavuza We-pancreatic:

I-Paclitaxel ivame ukusetshenziswa kanye neminye imithi ukusiza iziguli ukuthi zisinde umdlavuza we-pancreatic.

8. Ukwelashwa kwe-Non-hodgkin lymphoma:

I-Paclitaxeliphinde isetshenziswe ekwelapheni i-non-Hodgkin's lymphoma, ngokuvamile ihlanganiswa neminye imithi yokwelapha ngamakhemikhali ukuze kuncishiswe inqwaba ye-lymphoma.

9. Ukwelashwa kwezimila zobuchopho eziyinhloko noma ze-metastatic:

I-Paclitaxel ngezinye izikhathi isetshenziselwa ukwelapha izimila zobuchopho eziyinhloko noma ze-metastatic, kodwa idinga ukulawulwa kuwo wonke umgoqo wegazi nobuchopho, engakwazi ukuweqa kalula.

Sengiphetha, i-paclitaxel apis inezinhlelo zokusebenza ezibalulekile emikhakheni eminingi yomdlavuza.Ngokuphazamisa ukuhlukaniswa kwamaseli omdlavuza, kuvimbela ngempumelelo ukukhula nokusabalala kwamangqamuzana omdlavuza, kunikeze ithemba namathuba okwelashwa ezigulini.Nokho,paclitaxelUkwelashwa kubuye kuhlotshaniswe nemiphumela ethile engemihle, ngakho-ke uhlelo lokwelapha kufanele lunqunywe ngokuvumelana nesimo esithile sesiguli kanye nezincomo zikadokotela zokwandisa ukusebenza kahle nokunciphisa imiphumela emibi.

Qaphela: Izinzuzo ezingaba khona kanye nezicelo ezivezwe kulesi sihloko zithathwe ezincwadini ezishicilelwe.

I-Yunnan Hande Biotechnology Co., Ltd. ibigxile ekukhiqizeni i-paclitaxel iminyaka engu-26, futhi ingumkhiqizi ozimele we-anti-cancer drug paclitaxel API ekhishwe esitshalweni egunyazwe yi-United States FDA, European EDQM, Australia TGA, China CFDA , India, Japan kanye nezinye izinhlaka zokulawula zikazwelonke.Yunnan Hande paclitaxel, spot supply, factory direct sales, wamukelekile ukubuza, 18187887160 (WhatsApp inombolo efanayo)